- Grand Venture Technology (SGX:JLB)'s 1H22 revenue increased to $67.1m (+6.9% h-o-h, +25.3% y-o-y), in line with expectations. Although 1H22 revenue makes up 46.1% of our full year forecasts, we note that this is due to seasonality where first half is usually weaker.
- - Read this at SGinvestors.io -
- Life sciences: Growth in the life sciences segment was brought about by higher wallet share from new customers and higher production volumes for mass spectrometers and its related products. Customer supply chain constraints continue to dampen the growth of the life sciences segment.
- - Read this at SGinvestors.io -
Our Thoughts on Grand Venture Tech's 1H22
Further advancements into the semiconductor front end to mitigate back-end semiconductor customer weakness.
- Read more at SGinvestors.io.